Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE3.1200
- TODAY'S CHANGE (%)0.1800 (6.1224%)
- Bid / Lots3.0200/ 1
- Ask / Lots3.1500/ 20
- Open / Previous Close2.9400 / 2.9400
- Day Range
- 52 Week Range
- Volume743,191
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 11689 | 3.015 |
| 09:34 ET | 4682 | 3.01 |
| 09:36 ET | 5070 | 2.98 |
| 09:38 ET | 100 | 2.985 |
| 09:39 ET | 2513 | 2.99 |
| 09:41 ET | 1100 | 2.99 |
| 09:43 ET | 700 | 2.995 |
| 09:45 ET | 6343 | 3.03 |
| 09:48 ET | 55388 | 3.0401 |
| 09:50 ET | 7229 | 3.06 |
| 09:52 ET | 1150 | 3.055 |
| 09:54 ET | 7482 | 3.0301 |
| 09:56 ET | 500 | 3.035 |
| 09:57 ET | 5378 | 3.035 |
| 09:59 ET | 1080 | 3.02 |
| 10:01 ET | 731 | 3.005 |
| 10:03 ET | 959 | 3.02 |
| 10:06 ET | 8346 | 3.005 |
| 10:08 ET | 100 | 3.005 |
| 10:10 ET | 3457 | 3.01 |
| 10:12 ET | 200 | 3.015 |
| 10:14 ET | 460 | 3.015 |
| 10:15 ET | 378 | 3.02 |
| 10:17 ET | 744 | 3.015 |
| 10:19 ET | 3990 | 3.035 |
| 10:21 ET | 3198 | 3.035 |
| 10:24 ET | 1952 | 3.03 |
| 10:26 ET | 3627 | 3.029304 |
| 10:28 ET | 3605 | 3.03 |
| 10:30 ET | 2528 | 3.0166 |
| 10:32 ET | 100 | 3.02 |
| 10:33 ET | 100 | 3.02 |
| 10:35 ET | 4412 | 3.0101 |
| 10:37 ET | 203 | 3.015 |
| 10:39 ET | 100 | 3.015 |
| 10:42 ET | 1900 | 3.015 |
| 10:44 ET | 826 | 3.015 |
| 10:46 ET | 6450 | 3.015 |
| 10:48 ET | 400 | 3.02 |
| 10:50 ET | 100 | 3.015 |
| 10:51 ET | 2997 | 3.025 |
| 10:53 ET | 1610 | 3.025 |
| 10:55 ET | 2289 | 3.02 |
| 10:57 ET | 400 | 3.0112 |
| 11:00 ET | 400 | 3.015 |
| 11:02 ET | 715 | 3.02 |
| 11:04 ET | 3148 | 3.025 |
| 11:06 ET | 25624 | 3.015 |
| 11:09 ET | 331 | 3.02 |
| 11:11 ET | 3925 | 3.025 |
| 11:13 ET | 5900 | 3.045 |
| 11:15 ET | 1300 | 3.04 |
| 11:18 ET | 2152 | 3.0391 |
| 11:20 ET | 712 | 3.035 |
| 11:22 ET | 200 | 3.035 |
| 11:24 ET | 6384 | 3.025 |
| 11:26 ET | 100 | 3.025 |
| 11:27 ET | 2300 | 3.02 |
| 11:29 ET | 7121 | 3.035 |
| 11:31 ET | 2726 | 3.025 |
| 11:33 ET | 200 | 3.03 |
| 11:36 ET | 3648 | 3.04 |
| 11:40 ET | 3715 | 3.05 |
| 11:42 ET | 2923 | 3.06 |
| 11:44 ET | 4512 | 3.0687 |
| 11:45 ET | 2000 | 3.0632 |
| 11:49 ET | 5638 | 3.08 |
| 11:51 ET | 1886 | 3.075 |
| 11:54 ET | 4719 | 3.085 |
| 11:56 ET | 2195 | 3.08 |
| 11:58 ET | 800 | 3.09 |
| 12:00 ET | 603 | 3.085 |
| 12:02 ET | 2966 | 3.0889 |
| 12:03 ET | 7508 | 3.085 |
| 12:05 ET | 100 | 3.085 |
| 12:07 ET | 500 | 3.085 |
| 12:09 ET | 300 | 3.08 |
| 12:14 ET | 2200 | 3.09 |
| 12:16 ET | 4650 | 3.09 |
| 12:18 ET | 4016 | 3.085 |
| 12:20 ET | 1819 | 3.085 |
| 12:21 ET | 2173 | 3.085 |
| 12:23 ET | 500 | 3.085 |
| 12:25 ET | 11731 | 3.095 |
| 12:27 ET | 300 | 3.095 |
| 12:30 ET | 333 | 3.095 |
| 12:32 ET | 2612 | 3.105 |
| 12:34 ET | 1100 | 3.1 |
| 12:36 ET | 1600 | 3.105 |
| 12:38 ET | 1060 | 3.105 |
| 12:39 ET | 5363 | 3.125 |
| 12:41 ET | 7411 | 3.125 |
| 12:43 ET | 288 | 3.125 |
| 12:45 ET | 10355 | 3.15 |
| 12:48 ET | 23824 | 3.13 |
| 12:50 ET | 13170 | 3.13 |
| 12:52 ET | 6501 | 3.115 |
| 12:54 ET | 2500 | 3.11 |
| 12:56 ET | 400 | 3.12 |
| 12:57 ET | 443 | 3.115 |
| 12:59 ET | 4291 | 3.11 |
| 01:01 ET | 2528 | 3.1059 |
| 01:03 ET | 100 | 3.105 |
| 01:06 ET | 2062 | 3.105 |
| 01:08 ET | 100 | 3.11 |
| 01:10 ET | 1977 | 3.115 |
| 01:12 ET | 1168 | 3.12 |
| 01:14 ET | 437 | 3.115 |
| 01:15 ET | 641 | 3.115 |
| 01:17 ET | 200 | 3.115 |
| 01:19 ET | 1200 | 3.115 |
| 01:21 ET | 4969 | 3.12 |
| 01:24 ET | 2942 | 3.115 |
| 01:28 ET | 3944 | 3.11 |
| 01:30 ET | 438 | 3.101313 |
| 01:32 ET | 600 | 3.105 |
| 01:33 ET | 100 | 3.1 |
| 01:35 ET | 1004 | 3.1 |
| 01:37 ET | 300 | 3.1 |
| 01:39 ET | 3208 | 3.105 |
| 01:42 ET | 100 | 3.105 |
| 01:44 ET | 100 | 3.105 |
| 01:46 ET | 2720 | 3.115 |
| 01:48 ET | 2612 | 3.115 |
| 01:50 ET | 578 | 3.115 |
| 01:51 ET | 471 | 3.11 |
| 01:53 ET | 4834 | 3.11 |
| 01:55 ET | 807 | 3.11 |
| 01:57 ET | 400 | 3.11 |
| 02:00 ET | 300 | 3.11 |
| 02:02 ET | 600 | 3.11 |
| 02:04 ET | 1159 | 3.105 |
| 02:06 ET | 200 | 3.1013 |
| 02:08 ET | 700 | 3.105 |
| 02:09 ET | 434 | 3.11 |
| 02:11 ET | 100 | 3.105 |
| 02:13 ET | 100 | 3.105 |
| 02:15 ET | 200 | 3.105 |
| 02:20 ET | 100 | 3.11 |
| 02:22 ET | 2642 | 3.115 |
| 02:24 ET | 1043 | 3.115 |
| 02:26 ET | 1260 | 3.11 |
| 02:27 ET | 700 | 3.11 |
| 02:29 ET | 1000 | 3.11 |
| 02:31 ET | 300 | 3.11 |
| 02:33 ET | 5454 | 3.11 |
| 02:36 ET | 200 | 3.105 |
| 02:38 ET | 2743 | 3.1119 |
| 02:40 ET | 370 | 3.115 |
| 02:42 ET | 200 | 3.12 |
| 02:44 ET | 1910 | 3.115 |
| 02:45 ET | 100 | 3.12 |
| 02:47 ET | 200 | 3.12 |
| 02:49 ET | 3079 | 3.125 |
| 02:51 ET | 110 | 3.125 |
| 02:54 ET | 300 | 3.1214 |
| 02:58 ET | 300 | 3.125 |
| 03:00 ET | 603 | 3.1254 |
| 03:02 ET | 404 | 3.1296 |
| 03:03 ET | 4261 | 3.125 |
| 03:05 ET | 2131 | 3.135 |
| 03:07 ET | 340 | 3.135 |
| 03:14 ET | 2724 | 3.14 |
| 03:16 ET | 800 | 3.14 |
| 03:18 ET | 1700 | 3.145 |
| 03:20 ET | 4134 | 3.14 |
| 03:21 ET | 130 | 3.135 |
| 03:23 ET | 1580 | 3.135 |
| 03:25 ET | 1263 | 3.135 |
| 03:27 ET | 400 | 3.135 |
| 03:32 ET | 100 | 3.135 |
| 03:34 ET | 10550 | 3.125 |
| 03:36 ET | 992 | 3.125 |
| 03:38 ET | 11356 | 3.115 |
| 03:39 ET | 1976 | 3.11 |
| 03:41 ET | 1080 | 3.115 |
| 03:45 ET | 2150 | 3.11 |
| 03:48 ET | 11673 | 3.125 |
| 03:50 ET | 5200 | 3.1202 |
| 03:52 ET | 5063 | 3.115 |
| 03:54 ET | 700 | 3.12 |
| 03:56 ET | 2950 | 3.115 |
| 03:57 ET | 15440 | 3.105 |
| 03:59 ET | 109048 | 3.12 |
Oct 3, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 3:06PM ET on Thursday Oct 03, 2024 by Dow Jones
3:06PM ET on Thursday Oct 03, 2024 by Dow Jones
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 212.4M | -1.3x | --- |
Amarin Corporation PLC | 248.9M | -7.4x | --- |
Organogenesis Holdings Inc | 408.3M | -24.6x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ironwood Pharmaceuticals Inc | 686.9M | 99.5x | --- |
Coherus BioSciences Inc | 119.8M | -2.6x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $212.4M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
